Clinical trials
Parasitic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Recruiting | 7 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| No longer available | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| DBL -Institute for Health Research and Development | 3 |
| Drugs for Neglected Diseases | 3 |
| GlaxoSmithKline | 3 |
| Medicines for Malaria Venture | 3 |
| University of California, San Francisco | 3 |
| University of Oxford | 3 |
| Proto Pharma Ltd | 2 |
| Swiss Tropical & Public Health Institute | 2 |
| Aga Khan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parasitic Diseases | 55 |
| Malaria | 18 |
| Malaria, Falciparum | 12 |
| Protozoan Infections | 9 |
| Infections | 6 |
| Neglected Diseases | 5 |
| Bacterial Infections | 4 |
| Filariasis | 4 |
| Helminthiasis | 4 |
| Onchocerciasis | 4 |
Trials
Showing 51 to 55 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.